Eton Pharmaceuticals, Inc.
ETON
$58.83
-$0.52-0.87%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 12.69M | -1.48M | -4.60M | -6.68M | -4.13M |
| Total Depreciation and Amortization | 4.54M | 4.16M | 4.04M | 3.38M | 2.65M |
| Total Amortization of Deferred Charges | 632.00K | 520.00K | 696.00K | 1.56M | 1.40M |
| Total Other Non-Cash Items | 10.18M | 11.00M | 11.35M | 9.53M | 7.85M |
| Change in Net Operating Assets | -12.91M | 1.64M | -969.00K | 13.52M | 4.46M |
| Cash from Operations | 15.14M | 15.84M | 10.52M | 21.31M | 12.24M |
| Capital Expenditure | -403.00K | -408.00K | -333.00K | -296.00K | -12.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -30.00M | -30.00M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -15.00M | -15.00M | -- | -8.12M | -8.12M |
| Cash from Investing | -15.40M | -15.41M | -333.00K | -38.42M | -38.13M |
| Total Debt Issued | -- | -- | -- | 25.31M | 25.31M |
| Total Debt Repaid | -3.00M | -- | -- | 0.00 | -385.00K |
| Issuance of Common Stock | 4.73M | 1.81M | 815.00K | 8.66M | 8.66M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1.73M | 1.81M | 815.00K | 33.97M | 33.58M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.47M | 2.24M | 11.01M | 16.86M | 7.69M |